Vimarsana
Biggest News Aggregation in the World

Page 2 - Amputation Prevention News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Amputation Prevention. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Amputation Prevention Today - Breaking & Trending Today

FDA Clears Angioplasty Platform to Crack, Break, and Dilate Stenosis in Calcified Cardiovascular Disease and Hemodialysis Fistula - Vimarsana News

FDA Clears Angioplasty Platform to Crack, Break, and Dilate Stenosis in Calcified Cardiovascular Disease and Hemodialysis Fistula

/PRNewswire/ -- Transit Scientific, a pioneer in developing medical devices to treat calcified cardiovascular disease, dilate stenosed intimal hyperplasia, and...

American Diabetes Association Launches Amputation Prevention Alliance - Vimarsana News

American Diabetes Association Launches Amputation Prevention Alliance

American Diabetes Association launches Amputation Prevention Alliance to prevent amputations for all people living with diabetes.

American Diabetes Association Unveils Amputation Prevention Alliance to Address the Diabetes-Related Amputation Pandemic - Vimarsana News

American Diabetes Association Unveils Amputation Prevention Alliance to Address the Diabetes-Related Amputation Pandemic

/PRNewswire/ -- Today, the American Diabetes Association® announced a new initiative designed to address the urgent public health challenge of preventable...

Cordis Announces Start of Enrollment in RADIANCY Clinical Study in Europe - Vimarsana News

Cordis Announces Start of Enrollment in RADIANCY Clinical Study in Europe

Multi-center study to evaluate safety and efficacy of S.M.A.R.T. RADIANZ Vascular Stent System via Radial Access MIAMI LAKES, Fla., July 14, 2022 /PRNewswire/ -- Cordis, a global leader

Cordis' SMART Radianz Transradial Vascular Stent System Studied in Europe - Vimarsana News

Cordis' SMART Radianz Transradial Vascular Stent System Studied in Europe

July 14, 2022—Cordis announced the start of the RADIANCY premarket clinical study in Europe. According to the company, RADIANCY is a prospect